The circadian clock geneBMAL1is a novel therapeutic target for malignant pleural mesothelioma

Anaphase Catastrophe Is a Target for Cancer Therapy

(2011) Fabrizio Galimberti et al.   CLINICAL CANCER RESEARCH

Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer

(2011) Oshima   ONCOLOGY REPORTS

Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells

(2010) Yoshihiro Takeyama et al.   CANCER LETTERS

Epigenetic Inactivation of the Circadian Clock Gene BMAL1 in Hematologic Malignancies

(2009) H. Taniguchi et al.   CANCER RESEARCH

A Role for the Clock Gene Per1 in Prostate Cancer

(2009) Q. Cao et al.   CANCER RESEARCH

Malignant Pleural Mesothelioma

(2009) Anne S. Tsao et al.   JOURNAL OF CLINICAL ONCOLOGY

CtBPs Promote Cell Survival through the Maintenance of Mitotic Fidelity

(2009) L. M. Bergman et al.   MOLECULAR AND CELLULAR BIOLOGY

A Large Scale shRNA Barcode Screen Identifies the Circadian Clock Component ARNTL as Putative Regulator of the p53 Tumor Suppressor Pathway

(2009) Jasper Mullenders et al.   PLoS One

Genome-Wide Profile of Pleural Mesothelioma versus Parietal and Visceral Pleura: The Emerging Gene Portrait of the Mesothelioma Phenotype

(2009) Oluf Dimitri Røe et al.   PLoS One

Disturbance of circadian gene expression in breast cancer

(2009) Shou-Jen Kuo et al.   VIRCHOWS ARCHIV

The expression of the ΔNp73β isoform of p73 leads to tetraploidy

(2008) E. Marrazzo et al.   EUROPEAN JOURNAL OF CANCER

The adenovirus E4orf4 protein induces growth arrest and mitotic catastrophe in H1299 human lung carcinoma cells

(2008) S Li et al.   ONCOGENE

Molecular biology of malignant mesothelioma

(2008) Yoshitaka Sekido   Environmental Health and Preventive Medicine